DE602007011573D1 - Verfahren zur behandlung von demyelinierenden krankheiten - Google Patents

Verfahren zur behandlung von demyelinierenden krankheiten

Info

Publication number
DE602007011573D1
DE602007011573D1 DE602007011573T DE602007011573T DE602007011573D1 DE 602007011573 D1 DE602007011573 D1 DE 602007011573D1 DE 602007011573 T DE602007011573 T DE 602007011573T DE 602007011573 T DE602007011573 T DE 602007011573T DE 602007011573 D1 DE602007011573 D1 DE 602007011573D1
Authority
DE
Germany
Prior art keywords
treatment
demyelinating diseases
demyelinating
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007011573T
Other languages
English (en)
Inventor
Burkhard Becher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Zuerich
Original Assignee
Universitaet Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Zuerich filed Critical Universitaet Zuerich
Priority claimed from PCT/EP2007/051692 external-priority patent/WO2007096396A2/en
Publication of DE602007011573D1 publication Critical patent/DE602007011573D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
DE602007011573T 2006-02-22 2007-02-21 Verfahren zur behandlung von demyelinierenden krankheiten Active DE602007011573D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06110301 2006-02-22
US79279506P 2006-04-18 2006-04-18
PCT/EP2007/051692 WO2007096396A2 (en) 2006-02-22 2007-02-21 Methods for treating autoimmune or demyelinating diseases

Publications (1)

Publication Number Publication Date
DE602007011573D1 true DE602007011573D1 (de) 2011-02-10

Family

ID=36273431

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007011573T Active DE602007011573D1 (de) 2006-02-22 2007-02-21 Verfahren zur behandlung von demyelinierenden krankheiten

Country Status (3)

Country Link
AT (1) ATE493443T1 (de)
DE (1) DE602007011573D1 (de)
ES (1) ES2358929T3 (de)

Also Published As

Publication number Publication date
ATE493443T1 (de) 2011-01-15
ES2358929T3 (es) 2011-05-16

Similar Documents

Publication Publication Date Title
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
DE602005012489D1 (de) Verfahren zur Abwasserbehandlung
DE602006018583D1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
DE602005009866D1 (de) Verfahren zur herstellung von n-phenylpyrazol-1-carboxamiden
DE602005018601D1 (de) Verfahren zur herstellung von 2-aminothiazol-5-aro
DE602006018354D1 (de) Verfahren zur behandlung von abnormalem zellwachstum
DE502005002059D1 (de) Verfahren zur herstellung von polyetheralkoholen
DE602007013512D1 (de) Verfahren zur kontinuierlichen Herstellung von Bauteilen
DE602004021790D1 (de) Verfahren zur behandlung von parkinson-krankheit
DE602005016292D1 (de) Verfahren zur herstellung von glatiramer
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
ATE447551T1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
DE602006014670D1 (de) Verfahren zur doppelbindungs-hydroisomerisierung von butenen
DE602005007734D1 (de) Verfahren zur herstellung von telmisartan
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
DE602006010302D1 (de) Verfahren zur Herstellung von 5-methyl-2-furfural
DE602007001518D1 (de) Verfahren zur Behandlung von Beton
DE602005017099D1 (de) Verfahren zur Herstellung von amorphem Cefuroximaxetil
DE602006009562D1 (de) Verfahren zur herstellung von ferrisuccinylcasein
ATE537178T1 (de) Neue klasse von spiro-piperidinen zur behandlung neurodegenerativer krankheiten
DE602007003135D1 (de) Verfahren zur Herstellung von Xylylenediamin
DE602006018182D1 (de) Verfahren zur herstellung von aralkyloxypyrrolidinderivaten
DE502007000222D1 (de) Verfahren zur Herstellung von Methylchlorsilanen
DE602007012716D1 (de) Verfahren zur herstellung von amidrazonen